Dea

By

29/10/2026

Rescheduling Questions Linger for Dispensaries, Patients, and Hemp Operators

A webinar on DEA enforcement and cannabis rescheduling drew more questions than a single hour could answer, and the gaps matter. Operators, patients, and hemp businesses are making real decisions

• DEA

By

09/07/2026

Wyoming Blocks Federal Marijuana Rescheduling, Leaving Operators With No Path In

Wyoming's attorney general has formally objected to the federal reclassification of medical marijuana under the Controlled Substances Act, effectively blocking any rescheduling effect within state

• Wyoming

By

02/06/2026

Pharma-Pathway Cannabis Developer Challenges DEA Rescheduling Order in Federal Court

A company that spent years building a federally compliant cannabinoid drug development program is now suing the DEA over the agency's marijuana rescheduling order - and its core argument is that

• MMJ International Holdings

By

11/05/2026

DOJ Moves Medical Cannabis to Schedule III, Reshaping Operator Economics Overnight

On April 23, 2026, the Department of Justice issued an Order placing state-licensed medical cannabis in Schedule III of the Controlled Substances Act - effective immediately. The action, taken

• DOJ

By

03/05/2026

Marijuana Rescheduling Strips the IRS's Harshest Cannabis Tax Rule for Medical Operators

For the first time in the modern history of federal cannabis enforcement, state-licensed medical marijuana businesses are positioned to claim ordinary business deductions on their federal tax

• marijuana rescheduling